Peptide merchant account UK: how to take card payments selling peptides

Mainstream processors classify research peptides alongside unlicensed medicines and research chemicals, which their terms prohibit. They reject at onboarding, or onboard you and then terminate and hold funds once the catalogue is reviewed or a chargeback flags the account. It is a category decision, not a reflection of your specific business, and reapplying with the same setup does not change the outcome. You need a specialist high-risk acquirer that underwrites research-chemical catalogues instead.

Research peptides can be sold lawfully in the UK only as research chemicals or laboratory reagents, labelled not for human consumption. The moment a product is marketed for human use, dosing or injection it becomes an unlicensed medicine under MHRA rules, which is unlawful to sell. The legal position depends entirely on how the product is presented, so labelling and the absence of human-use claims are what keep you compliant. GLP-1 peptides such as semaglutide are prescription-only medicines and a separate, more serious matter.

Not the mainstream names. UK peptide sellers route through specialist research-chemical and nutraceutical acquirers that underwrite the category case-by-case, looking at your labelling, claims, volume and processing history. There is no single published list because acceptance depends on your exact profile, which is why most sellers come through a broker who knows which underwriter is most likely to take a given catalogue.

Expect blended rates around 3.5% to 6.0% and a rolling reserve of roughly 10% to 20% held against chargebacks and regulatory risk, plus standard gateway and scheme fees. Rates depend on your volume, processing history and how cleanly your site is presented. A compliant, claim-free catalogue with proper labelling is underwritten at the lower end; a site with human-use claims is either loaded heavily or declined.

You can build the storefront on Shopify, but Shopify Payments (powered by Stripe) will not process research peptides and will shut the account on review. You connect a third-party high-risk gateway and acquirer to Shopify instead. The storefront platform is not the problem; the payment rail behind it is, and that is the piece a specialist account solves.

A rolling reserve is a percentage of your takings the acquirer holds back, typically for 90 to 180 days, as security against future chargebacks and refunds. High-risk categories carry one because the acquirer is exposed if disputes spike or the account is terminated. On peptides a 10% to 20% reserve is normal. It is your money, released on a rolling schedule, but you need to plan cash flow around it.

Start with a specialist acquirer that knows the category, not a mainstream processor that will onboard and then freeze you. Disclose the risk classification upfront so the right underwriter is approached from the start, get your labelling and disclaimers compliant before you apply, and keep all human-use and health claims off the site. Applying cold and being declined leaves a record that makes the next application harder, so the order you apply in matters.